Configuration

ClusPro BM5 Table1 antibody

Antibody-specific mode; Table1 does not explicitly label a masking condition. Do not infer masking from separate Figure3 experiments.

4 evaluations · 40 results

Overview

Antibody-specific mode; Table1 does not explicitly label a masking condition. Do not infer masking from separate Figure3 experiments.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

4 evaluations · 40 results. Different protocols are not a single leaderboard.

Filter evaluations

Tested model or methodProtocolDatasetEvaluation setupMetricEvidence origin

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configuration	Protocol and dataset	Finding	Evidence and details
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	7 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models Number
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	7 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	2 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	4 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	N/A acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; intermediate column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort	58.3% success_at_10 percent · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models %
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	10 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models Number
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	10 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	3 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	6 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	N/A acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; intermediate column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort	83.3% success_at_30 percent · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Bound antibody top30 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models %
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	12 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models Number
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	11 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibody	Protocol: ClusPro BM5 Unbound antibody top10 Dataset subset: BM5 Unbound antibody Table1 cohort	6 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible	Author-reported evaluation · Source checked Methods, coverage and source ClusPro Unbound antibody top10 Not reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; medium_accuracy_targets

Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.

Use this model

How it works, versions and access

Related profile: ClusPro rigid-body docking. This page retains the exact record and its evaluation context.

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-09-30-e37e3ab1284d
Property and statement	Original source and location	Review and provenance
Relationship: variant of ucc-docking-cluspro-bm5-2020-method Individual claims	Performance and its limits in rigid body protein-protein docking Original source ↗ Results and STAR Methods ClusPro Docking Server Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597 Retrieved: 2026-09-30T21:50:23.483497+00:00	source checked automated source review · 2026-09-30T21:50:23.483497+00:00 Audit details Source transcription only; not execution, human scientific review or independent reproduction. Field: `links:variant_of:ucc-docking-cluspro-bm5-2020-method` Claim: ucc-docking-cluspro-bm5-2020-claim-config-antibody Source artifact SHA-256: `1c02bd7c53eb0e5d5c243b5e6da23168eb20bcc32ab970719666a5838fd58443` Hash scope: Hash scope not separately documented; inspect source record Inspected artifact

All evidence (CSV)All evidence (JSONL)How to read the evidence

Sources and history

View linked audit checks and correction history

Release 2026-09-30-e37e3ab1284d · Record review: source checked

1 source records and release history

Performance and its limits in rigid body protein-protein docking · Original source · Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597

Download this release

Technical metadata and extraction receipts

Stable ID: ucc-docking-cluspro-bm5-2020-config-antibody

areas: proteins-complexes
version: 2020 author configuration
source locator: Results paragraph preceding Table1; STAR Methods ClusPro Docking Server
review: method: automated_source_review; reviewed at: 2026-09-30T21:50:23.483497+00:00; date: 2026-09-30; reviewer: Codex primary-source table extraction; note: Source transcription only; not execution, human scientific review or independent reproduction.
missing metadata: software commit: unextracted; exact input structure hashes: unextracted

Related records

variant of: ClusPro rigid-body docking
configuration: ClusPro conventional docking baseline: Bound antibody
configuration: ClusPro conventional docking baseline: Unbound antibody
subject: ClusPro antibody identity
configuration: ClusPro Bound antibody top10
configuration: ClusPro Bound antibody top30
configuration: ClusPro Unbound antibody top10
configuration: ClusPro Unbound antibody top30

Suggest a correction